You are here

Vertex Pharmaceuticals

Vertex’s second try at a rare lung disorder

Vertex’s second try at a rare lung disorder

EP Vantage

Vertex Pharmaceuticals

alpha-1 antitrypsin

Flag link:

Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient

Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient

Endpoints

Vertex Pharmaceuticals

Flag link:

The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic

The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic

Endpoints

Vertex Pharmaceuticals

Semma Therapeutics

type 1 diabetes

Flag link:

Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA

Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA

Yahoo/Zacks.com

Vertex Pharmaceuticals

cystic fibrosis

priority revies

Flag link:

10 key clinical trials to watch in the first half of 2021

10 key clinical trials to watch in the first half of 2021

BioPharma Dive

clinical trials

SAGE Therapeutics

Vertex Pharmaceuticals

Flag link:

JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining

JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining

BioPharma Dive

Vertex Pharmaceuticals

Sarepta Therapeutics

Flag link:

Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify

Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify

BioPharma Dive

Vertex Pharmaceuticals

Skyhawk Therapeutics

small molecule drugs

Flag link:

Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting

Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting

Yahoo/Bloomberg

Trillium Therapeutics

CRISPR Therapeutics

Fate Therapeutics

Vertex Pharmaceuticals

Flag link:

Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia

Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia

Endpoints

Locus Biosciences

Vertex Pharmaceuticals

clinical trials

Flag link:

CRISPR and Vertex Release Additional Data for Blood Disease Treatment

CRISPR and Vertex Release Additional Data for Blood Disease Treatment

Motley Fool

CRISPR Therapeutics

Vertex Pharmaceuticals

beta thalassemia

sickle cell disease

Flag link:

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates

Yahoo/Zacks.com

Vertex Pharmaceuticals

Flag link:

Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug

Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug

Beckers Hospital Review

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex faces first notable setback as it pushes beyond cystic fibrosis

Vertex faces first notable setback as it pushes beyond cystic fibrosis

BioPharma Dive

Vertex Pharmaceuticals

clinical trials

Flag link:

Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants

Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants

Yahoo/Zacks.com

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Moderna lands $100M upfront in deals with Vertex, Chiesi

Moderna lands $100M upfront in deals with Vertex, Chiesi

Fierce Biotech

Moderna Therapeutics

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off

An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off

Endpoints

Vertex Pharmaceuticals

Alzheimer's disease

Flag link:

Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug

Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug

Motley Fool

Vertex Pharmaceuticals

clinical trials

Flag link:

How Vertex Pharmaceuticals Wowed With Its Q2 Results

How Vertex Pharmaceuticals Wowed With Its Q2 Results

Motley Fool

Vertex Pharmaceuticals

Flag link:

Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF

Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF

Business Insider

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment

CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment

Fierce Biotech

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

Pages